医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

BeiGene to Host Investor Conference Call and Webcast to Discuss the Company’s Early Development Pipeline and Research on August 25, 2021

2021年08月16日 PM08:00
このエントリーをはてなブックマークに追加


 

CAMBRIDGE, Mass. & BEIJING

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide, today announced that it will host an investor conference call and webcast on Wednesday, August 25, 2021, at 9:30 a.m. ET to discuss the Company’s early development pipeline and research.

A live webcast of the conference call can be accessed from the investors section of BeiGene’s website at http://ir.beigene.com or http://hkexir.beigene.com. An archived replay will be available after the event for 90 days.

About BeiGene

BeiGene is a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide. With a broad portfolio of more than 40 clinical candidates, we are expediting development of our diverse pipeline of novel therapeutics through our own capabilities and collaborations. We are committed to radically improving access to medicines for two billion more people by 2030. BeiGene has a growing global team of approximately 7,000 colleagues across five continents. To learn more about BeiGene, please visit www.beigene.com and follow us on Twitter at @BeiGeneGlobal.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210816005187/en/

CONTACT

Investor

Gabrielle Zhou

+86 10-5895-8058 or +1 857-302-5189

ir@beigene.com

Media

Liza Heapes or Vivian Ni

+1 857-302-5663 or +1 857-302-7596

media@beigene.com

同じカテゴリーの記事 

  • Rapid Medical™的主动进入解决方案获得美国FDA批准并在美完成首次神经血管病例治疗
  • ラピッド・メディカル™、アクティブ・アクセス・ソリューションのFDA認可を受け米国初の神経血管手術を実施
  • PharmaEssentia Appoints Beth A. Krewson as Head of Legal
  • Samsara Vision Announces First SING IMT® (Smaller-Incision New-Generation Implantable Miniature Telescope) Patient in China and Accelerating Global Rollout
  • 2 Million Lives in Care – AIDS Healthcare Foundation Reaches a Historic Milestone